The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Synopsis
The global Genomics In Cancer Care market was valued at US$ 27620 million in 2023 and is anticipated to reach US$ 70990 million by 2030, witnessing a CAGR of 14.2% during the forecast period 2024-2030.
North American market for Genomics In Cancer Care is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Genomics In Cancer Care is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Genomics In Cancer Care in Diagnostics is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Genomics In Cancer Care include Illumina, Thermo Fisher scientific, Agilent, Roche, Cancer Genetics, Beckman Coulter, Bio-Rad, Danaher and Sigma Aldrich, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Genomics In Cancer Care, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Genomics In Cancer Care.
Report Scope
The Genomics In Cancer Care market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Genomics In Cancer Care market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Genomics In Cancer Care companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
- Illumina
- Thermo Fisher scientific
- Agilent
- Roche
- Cancer Genetics
- Beckman Coulter
- Bio-Rad
- Danaher
- Sigma Aldrich
- Pacific Biosciences
- Quest Diagnostics
- Luminex
- Oxford Gene Technology
- PerkinElmer
- Qiagen
- GE Healthcare
Segment by Type
- Instruments
- Consumables
- Services
Segment by Application
- Diagnostics
- Personalized Medicine
- Drug Discovery
- Development
- Research
Consumption by Region
- North America (United States, Canada)
- Europe (Germany, France, U.K., Italy, Netherlands)
- Asia-Pacific (China, Japan, South Korea, China Taiwan, Southeast Asia, India)
- Latin America, Middle East & Africa (Latin America, Mexico, Brazil, Turkey)
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Genomics In Cancer Care companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Genomics In Cancer Care Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Instruments
1.2.3 Consumables
1.2.4 Services
1.3 Market by Application
1.3.1 Global Genomics In Cancer Care Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Diagnostics
1.3.3 Personalized Medicine
1.3.4 Drug Discovery
1.3.5 Development
1.3.6 Research
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Genomics In Cancer Care Market Perspective (2019-2030)
2.2 Genomics In Cancer Care Growth Trends by Region
2.2.1 Global Genomics In Cancer Care Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Genomics In Cancer Care Historic Market Size by Region (2019-2024)
2.2.3 Genomics In Cancer Care Forecasted Market Size by Region (2025-2030)
2.3 Genomics In Cancer Care Market Dynamics
2.3.1 Genomics In Cancer Care Industry Trends
2.3.2 Genomics In Cancer Care Market Drivers
2.3.3 Genomics In Cancer Care Market Challenges
2.3.4 Genomics In Cancer Care Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Genomics In Cancer Care Players by Revenue
3.1.1 Global Top Genomics In Cancer Care Players by Revenue (2019-2024)
3.1.2 Global Genomics In Cancer Care Revenue Market Share by Players (2019-2024)
3.2 Global Genomics In Cancer Care Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Genomics In Cancer Care Revenue
3.4 Global Genomics In Cancer Care Market Concentration Ratio
3.4.1 Global Genomics In Cancer Care Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Genomics In Cancer Care Revenue in 2023
3.5 Genomics In Cancer Care Key Players Head office and Area Served
3.6 Key Players Genomics In Cancer Care Product Solution and Service
3.7 Date of Enter into Genomics In Cancer Care Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Genomics In Cancer Care Breakdown Data by Type
4.1 Global Genomics In Cancer Care Historic Market Size by Type (2019-2024)
4.2 Global Genomics In Cancer Care Forecasted Market Size by Type (2025-2030)
5 Genomics In Cancer Care Breakdown Data by Application
5.1 Global Genomics In Cancer Care Historic Market Size by Application (2019-2024)
5.2 Global Genomics In Cancer Care Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Genomics In Cancer Care Market Size (2019-2030)
6.2 North America Genomics In Cancer Care Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Genomics In Cancer Care Market Size by Country (2019-2024)
6.4 North America Genomics In Cancer Care Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Genomics In Cancer Care Market Size (2019-2030)
7.2 Europe Genomics In Cancer Care Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Genomics In Cancer Care Market Size by Country (2019-2024)
7.4 Europe Genomics In Cancer Care Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Genomics In Cancer Care Market Size (2019-2030)
8.2 Asia-Pacific Genomics In Cancer Care Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Genomics In Cancer Care Market Size by Region (2019-2024)
8.4 Asia-Pacific Genomics In Cancer Care Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Genomics In Cancer Care Market Size (2019-2030)
9.2 Latin America Genomics In Cancer Care Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Genomics In Cancer Care Market Size by Country (2019-2024)
9.4 Latin America Genomics In Cancer Care Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Genomics In Cancer Care Market Size (2019-2030)
10.2 Middle East & Africa Genomics In Cancer Care Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Genomics In Cancer Care Market Size by Country (2019-2024)
10.4 Middle East & Africa Genomics In Cancer Care Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Illumina
11.1.1 Illumina Company Detail
11.1.2 Illumina Business Overview
11.1.3 Illumina Genomics In Cancer Care Introduction
11.1.4 Illumina Revenue in Genomics In Cancer Care Business (2019-2024)
11.1.5 Illumina Recent Development
11.2 Thermo Fisher scientific
11.2.1 Thermo Fisher scientific Company Detail
11.2.2 Thermo Fisher scientific Business Overview
11.2.3 Thermo Fisher scientific Genomics In Cancer Care Introduction
11.2.4 Thermo Fisher scientific Revenue in Genomics In Cancer Care Business (2019-2024)
11.2.5 Thermo Fisher scientific Recent Development
11.3 Agilent
11.3.1 Agilent Company Detail
11.3.2 Agilent Business Overview
11.3.3 Agilent Genomics In Cancer Care Introduction
11.3.4 Agilent Revenue in Genomics In Cancer Care Business (2019-2024)
11.3.5 Agilent Recent Development
11.4 Roche
11.4.1 Roche Company Detail
11.4.2 Roche Business Overview
11.4.3 Roche Genomics In Cancer Care Introduction
11.4.4 Roche Revenue in Genomics In Cancer Care Business (2019-2024)
11.4.5 Roche Recent Development
11.5 Cancer Genetics
11.5.1 Cancer Genetics Company Detail
11.5.2 Cancer Genetics Business Overview
11.5.3 Cancer Genetics Genomics In Cancer Care Introduction
11.5.4 Cancer Genetics Revenue in Genomics In Cancer Care Business (2019-2024)
11.5.5 Cancer Genetics Recent Development
11.6 Beckman Coulter
11.6.1 Beckman Coulter Company Detail
11.6.2 Beckman Coulter Business Overview
11.6.3 Beckman Coulter Genomics In Cancer Care Introduction
11.6.4 Beckman Coulter Revenue in Genomics In Cancer Care Business (2019-2024)
11.6.5 Beckman Coulter Recent Development
11.7 Bio-Rad
11.7.1 Bio-Rad Company Detail
11.7.2 Bio-Rad Business Overview
11.7.3 Bio-Rad Genomics In Cancer Care Introduction
11.7.4 Bio-Rad Revenue in Genomics In Cancer Care Business (2019-2024)
11.7.5 Bio-Rad Recent Development
11.8 Danaher
11.8.1 Danaher Company Detail
11.8.2 Danaher Business Overview
11.8.3 Danaher Genomics In Cancer Care Introduction
11.8.4 Danaher Revenue in Genomics In Cancer Care Business (2019-2024)
11.8.5 Danaher Recent Development
11.9 Sigma Aldrich
11.9.1 Sigma Aldrich Company Detail
11.9.2 Sigma Aldrich Business Overview
11.9.3 Sigma Aldrich Genomics In Cancer Care Introduction
11.9.4 Sigma Aldrich Revenue in Genomics In Cancer Care Business (2019-2024)
11.9.5 Sigma Aldrich Recent Development
11.10 Pacific Biosciences
11.10.1 Pacific Biosciences Company Detail
11.10.2 Pacific Biosciences Business Overview
11.10.3 Pacific Biosciences Genomics In Cancer Care Introduction
11.10.4 Pacific Biosciences Revenue in Genomics In Cancer Care Business (2019-2024)
11.10.5 Pacific Biosciences Recent Development
11.11 Quest Diagnostics
11.11.1 Quest Diagnostics Company Detail
11.11.2 Quest Diagnostics Business Overview
11.11.3 Quest Diagnostics Genomics In Cancer Care Introduction
11.11.4 Quest Diagnostics Revenue in Genomics In Cancer Care Business (2019-2024)
11.11.5 Quest Diagnostics Recent Development
11.12 Luminex
11.12.1 Luminex Company Detail
11.12.2 Luminex Business Overview
11.12.3 Luminex Genomics In Cancer Care Introduction
11.12.4 Luminex Revenue in Genomics In Cancer Care Business (2019-2024)
11.12.5 Luminex Recent Development
11.13 Oxford Gene Technology
11.13.1 Oxford Gene Technology Company Detail
11.13.2 Oxford Gene Technology Business Overview
11.13.3 Oxford Gene Technology Genomics In Cancer Care Introduction
11.13.4 Oxford Gene Technology Revenue in Genomics In Cancer Care Business (2019-2024)
11.13.5 Oxford Gene Technology Recent Development
11.14 PerkinElmer
11.14.1 PerkinElmer Company Detail
11.14.2 PerkinElmer Business Overview
11.14.3 PerkinElmer Genomics In Cancer Care Introduction
11.14.4 PerkinElmer Revenue in Genomics In Cancer Care Business (2019-2024)
11.14.5 PerkinElmer Recent Development
11.15 Qiagen
11.15.1 Qiagen Company Detail
11.15.2 Qiagen Business Overview
11.15.3 Qiagen Genomics In Cancer Care Introduction
11.15.4 Qiagen Revenue in Genomics In Cancer Care Business (2019-2024)
11.15.5 Qiagen Recent Development
11.16 GE Healthcare
11.16.1 GE Healthcare Company Detail
11.16.2 GE Healthcare Business Overview
11.16.3 GE Healthcare Genomics In Cancer Care Introduction
11.16.4 GE Healthcare Revenue in Genomics In Cancer Care Business (2019-2024)
11.16.5 GE Healthcare Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
